Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDE4A | P27815 | 15/20 | 1.00 |
| ▸ | PDE4B | Q07343 | 15/20 | 1.00 |
| ▸ | PDE4C | Q08493 | 15/20 | 1.00 |
| ▸ | PDE4D | Q08499 | 15/20 | 1.00 |
| ▸ | PRKACA | P17612 | 1/20 | 0.73 |
| ▸ | PRKACG | P22612 | 1/20 | 0.73 |
| ▸ | PRKACB | P22694 | 1/20 | 0.73 |
| ▸ | STING1 | Q86WV6 | 2/20 | 0.68 |
| ▸ | LMNA | P02545 | 2/20 | 0.68 |
| ▸ | GMNN | O75496 | 1/20 | 0.68 |
| ▸ | RAPGEF3 | O95398 | 1/20 | 0.68 |
| ▸ | BLM | P54132 | 1/20 | 0.68 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.68 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.68 |
| ▸ | RAPGEF4 | Q8WZA2 | 1/20 | 0.68 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Tocladesine SCHEMBL29381763 | 1.00 | PDE4A (1.00) | PDE4APDE4BPDE4CPDE4DPRKACA | |
| Tocladesine SCHEMBL1651488 | 1.00 | PDE4A (1.00) | PDE4APDE4BPDE4CPDE4DPRKACA | |
| SCHEMBL9702440 | 0.90 | PDE4A (1.00) | PDE4APDE4BPDE4CPDE4DPRKACA | |
| SCHEMBL5951342 | 0.89 | PDE4A (1.00) | PDE4APDE4BPDE4CPDE4DPRKACA | |
| SCHEMBL29384358 | 0.89 | PDE4A (1.00) | PDE4APDE4BPDE4CPDE4DPRKACA | |
| SCHEMBL14261298 | 0.89 | PDE4A (0.82) | PDE4APDE4BPDE4CPDE4DPRKACA | |
| SCHEMBL29359388 | 0.89 | PDE4A (1.00) | PDE4APDE4BPDE4CPDE4DPRKACA | |
| SCHEMBL9505216 | 0.89 | PDE4A (0.82) | PDE4APDE4BPDE4CPDE4DPRKACA | |
| SCHEMBL2713659 | 0.89 | PDE4A (1.00) | PDE4APDE4BPDE4CPDE4DPRKACA | |
| SCHEMBL16079734 | 0.89 | PDE4A (1.00) | PDE4APDE4BPDE4CPDE4DPRKACA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1542 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4704904-A1 | TETRAZINE-BASED TARGETING AGENTS FOR IN VIVO DELIVERY OF A PAYLOAD | Tambo, Inc. (US) | 2026-03-11 | — | — | EP | claimed |
| EP-4687964-A2 | METHOD OF VACCINATING FOR CANCER AND DEVICE AND KIT THEREFOR | Purdue Research Foundation (US) | 2026-02-11 | — | — | EP | claimed |
| EP-4627061-A1 | CULTURE MEDIUM, COATING MATRIX AND METHOD FOR MATURING MIDBRAIN DOPAMINERGIC PROGENITOR CELLS | Nuwacell Biotechnologies Co., Ltd. (CN) | 2025-10-08 | — | — | EP | claimed |
| US-12391919-B2 | Culture medium, coating matrix and method for maturing midbrain dopaminergic progenitor cells | NUWACELL BIOTECHNOLOGIES CO., LTD. (CN) | 2025-08-19 | — | — | US | claimed |
| US-20250207092-A1 | CULTURE MEDIUM, COATING MATRIX AND METHOD FOR MATURING MIDBRAIN DOPAMINERGIC PROGENITOR CELLS | NUWACELL BIOTECHNOLOGIES CO., LTD. (CN) | 2025-06-26 | — | — | US | claimed |
| WO-2024229427-A1 | TETRAZINE-BASED TARGETING AGENTS FOR IN VIVO DELIVERY OF A PAYLOAD | TAMBO, INC. (US) | 2024-11-07 | — | — | WO | claimed |
| WO-2024207006-A2 | METHOD OF VACCINATING FOR CANCER AND DEVICE AND KIT THEREFOR | PURDUE RESEARCH FOUNDATION (US) | 2024-10-03 | — | — | WO | claimed |
| EP-4427588-A2 | COMPOSITIONS FOR HEMOLYSIS AND COAGULATION REGULATION AND STABILIZATION OF EXTRACELLULAR VESICLES | Streck LLC (US) | 2024-09-11 | — | — | EP | claimed |
| EP-4422696-A1 | TETRAZINE CONJUGATES FOR IN VIVO TARGETED DELIVERY OF A PAYLOAD | Tambo, Inc. (US) | 2024-09-04 | — | — | EP | claimed |
| CN-115119829-B | Compositions for the modulation of haemolysis and coagulation of extracellular vesicles and stabilization | 斯特雷克股份有限公司 | 2024-07-12 | — | — | CN | claimed |
| WO-2003065994-A2 | SCHWANN CELL AND PHOSPHODIESTERASE INHIBITORS BASED THERAPY | UNIVERSITY OF MIAMI (US) | 2003-08-14 | — | — | WO | claimed |
| US-20030134821-A1 | Promoters of neural regeneration | NIH-DEITR | 2003-07-17 | — | — | US | claimed |
| US-20030134820-A1 | Promoters of neural regeneration | NIH-DEITR | 2003-07-17 | — | — | US | claimed |
| US-6284539-B1 | IDENTIFYING CELLS EXPRESSING TYROSINE HYDROXYLASE; INCUBATING STEM CELLS WITH POLYNUCLEOTIDE ENCODING TRANSCRIPTION REGULATOR; PARKINSON'S DISEASE; DOPAMINERGIC CELL FATE | NEURALSTEM BIOPHARMACEUTICALS, LTD. | 2001-09-04 | — | — | US | claimed |
| US-6268352-B1 | Promoters of neural regeneration | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA | 2001-07-31 | — | — | US | claimed |
| EP-1109561-A1 | PROMOTERS OF NEURAL REGENERATION | The Regents of the University of California (US) | 2001-06-27 | — | — | EP | claimed |
| WO-2000012099-A1 | PROMOTERS OF NEURAL REGENERATION | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2000-03-09 | — | — | WO | claimed |
| WO-1999032605-A1 | METHOD FOR PRODUCING HETEROLOGOUS PROTEINS IN EUKARYOTIC CELLS ON AN INDUSTRIAL SCALE USING NUCLEOTIDE-MANIPULATING AGENTS | NOVO NORDISK A/S (DK) | 1999-07-01 | — | — | WO | claimed |
| US-5693521-A | USING ACETOXYALKYL ESTER OF ADENOSINE(OR GUANOSINE)-3',5'-CYCLIC MONNOPHOSPHATE | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 1997-12-02 | — | — | US | claimed |
| WO-1994023724-A1 | MEMBRANE-PERMEANT SECOND MESSENGERS | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 1994-10-27 | — | — | WO | claimed |